Literature DB >> 19879735

The role of dendritic cell subsets in 2,4,6-trinitrobenzene sulfonic acid-induced ileitis.

Shoichi Hoshino1, Muneo Inaba, Hiroshi Iwai, Tomoki Ito, Ming Li, M Eric Gershwin, Kazuichi Okazaki, Susumu Ikehara.   

Abstract

Dendritic cells (DCs) are widely distributed throughout the lymphoid and nonlymphoid tissues, and are important initiators of acquired immunity and also serve as regulators by inducing self-tolerance. However, it has not been thoroughly clarified whether DCs are involved in the termination of immune responses. In this paper, we have examined the kinetical movement of dendritic cells (DCs) in the lamina propria using the 2,4,6-trinitrobenzene sulfonic acid (TNBS)-induced ileitis model (an animal model for Crohn's disease). Increased numbers of DCs were recruited to the inflammatory sites from day 1 to day 3 at which time the inflammatory responses was clearly observed, then gradually decreased to a steady-state level on day 7 along with the cessation of responses. Three subsets of DCs, PIR-A/B(high), PIR-A/B(med), and PIR-A/B(-) DCs in the CD11c(+)/B220(-) conventional DCs (cDCs) were noted on day 3; the number of PIR-A/B(med) cDCs increased when the inflammatory responses ceased on day 7. The expression of costimulatory molecules such as CD86 and CD54 was lower in the PIR-A/B(med) DCs compared with the other two cDC subsets or splenic DCs. Furthermore, the stimulatory activity of PIR-A/B(med) cDCs was lower than those of PIR-A/B(high) or PIR-A/B(-) cDCs, and far lower than that of splenic DCs. In addition, an increase in the message level of IL-10 was clearly observed in the PIR-A/B(med) cDCs on day 7 while that of proinflammatory cytokines such as IL-6 and IL-12 was low. These data demonstrate that PIR-A/B(med) cDCs which increase at the final stage of inflammation may be involved in the termination of the TNBS-induced ileitis by the delivery of anergic signals to effector T cells due to the lower expressions of costimulatory molecules and the production of immunoregulatory cytokine.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19879735     DOI: 10.1016/j.jaut.2009.10.002

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  5 in total

1.  Amelioration of 2,4,6-trinitrobenzene sulfonic acid-induced colitis in mice by immunoregulatory dendritic cells.

Authors:  Shoichi Hoshino; Akiko Kurishima; Muneo Inaba; Yugo Ando; Toshiro Fukui; Kazushige Uchida; Akiyoshi Nishio; Hiroshi Iwai; Takashi Yokoi; Tomoki Ito; Sanae Hasegawa-Ishii; Atsuyoshi Shimada; Ming Li; Kazuichi Okazaki; Susumu Ikehara
Journal:  J Gastroenterol       Date:  2011-09-16       Impact factor: 7.527

2.  Induction of PIR-A/B+ DCs in the in vitro inflammatory condition and their immunoregulatory function.

Authors:  Fumi Matsui; Muneo Inaba; Kazushige Uchida; Akiyoshi Nishio; Toshiro Fukui; Hideaki Yoshimura; Atsushi Satake; Kazuhiko Yoshioka; Shosaku Nomura; Kazuichi Okazaki
Journal:  J Gastroenterol       Date:  2018-03-05       Impact factor: 7.527

3.  Immunoregulatory function of PIR-A/B+ DCs in the inflammatory responses of dextran sodium sulfate-induced colitis.

Authors:  Akiko Kurishima; Muneo Inaba; Yutaku Sakaguchi; Toshiro Fukui; Kazushige Uchida; Akiyoshi Nishio; Shosaku Nomura; Kazuichi Okazaki
Journal:  J Gastroenterol       Date:  2013-09-29       Impact factor: 7.527

4.  Curcumin Suppressed Activation of Dendritic Cells via JAK/STAT/SOCS Signal in Mice with Experimental Colitis.

Authors:  Hai-Mei Zhao; Rong Xu; Xiao-Ying Huang; Shao-Min Cheng; Min-Fang Huang; Hai-Yang Yue; Xin Wang; Yong Zou; Ai-Ping Lu; Duan-Yong Liu
Journal:  Front Pharmacol       Date:  2016-11-25       Impact factor: 5.810

5.  Whole-genome microarray analysis and functional characterization reveal distinct gene expression profiles and patterns in two mouse models of ileal inflammation.

Authors:  Leela Rani Avula; Dries Knapen; Roeland Buckinx; Lucia Vergauwen; Dirk Adriaensen; Luc Van Nassauw; Jean-Pierre Timmermans
Journal:  BMC Genomics       Date:  2012-08-06       Impact factor: 3.969

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.